Race Oncology Ltd (RAC) - Total Liabilities

Latest as of December 2025: AU$1.20 Million AUD ≈ $847.04K USD

Based on the latest financial reports, Race Oncology Ltd (RAC) has total liabilities worth AU$1.20 Million AUD (≈ $847.04K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Race Oncology Ltd - Total Liabilities Trend (2011–2025)

This chart illustrates how Race Oncology Ltd's total liabilities have evolved over time, based on quarterly financial data. See Race Oncology Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Race Oncology Ltd Competitors by Total Liabilities

The table below lists competitors of Race Oncology Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Jiangsu Xinning Modern Logist SHE:300013	China	CN¥354.76 Million
Tiv Taam TA:TTAM	Israel	ILA1.16 Billion
Waterstone Financial Inc NASDAQ:WSBF	USA	$1.90 Billion
Balmer Lawrie & Company Limited NSE:BALMLAWRIE	India	Rs12.69 Billion
BTS Group AB (publ) ST:BTS-B	Sweden	Skr1.59 Billion
Voyager Acquisition Corp NASDAQ:VACH	USA	$286.73 Million
Viemed Healthcare Inc NASDAQ:VMD	USA	$66.86 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Race Oncology Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see RAC market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	18.37	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Race Oncology Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Race Oncology Ltd (2011–2025)

The table below shows the annual total liabilities of Race Oncology Ltd from 2011 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$1.48 Million ≈ $1.05 Million	-22.85%
2024-06-30	AU$1.92 Million ≈ $1.36 Million	+66.39%
2023-06-30	AU$1.15 Million ≈ $814.97K	-18.74%
2022-06-30	AU$1.42 Million ≈ $1.00 Million	+170.95%
2021-06-30	AU$523.11K ≈ $370.13K	+114.70%
2020-06-30	AU$243.65K ≈ $172.40K	+26.82%
2019-06-30	AU$192.12K ≈ $135.94K	-37.97%
2018-06-30	AU$309.71K ≈ $219.14K	-14.82%
2017-06-30	AU$363.57K ≈ $257.25K	-7.16%
2016-06-30	AU$391.62K ≈ $277.10K	+229.70%
2015-06-30	AU$118.78K ≈ $84.04K	-10.05%
2014-06-30	AU$132.05K ≈ $93.43K	-99.93%
2013-12-31	AU$191.01 Million ≈ $135.15 Million	+1611781.86%
2013-06-30	AU$11.85K ≈ $8.38K	-100.00%
2012-12-31	AU$264.98 Million ≈ $187.49 Million	-20.07%
2012-06-30	AU$331.51 Million ≈ $234.56 Million	+21.34%
2011-06-30	AU$273.20 Million ≈ $193.31 Million	--

About Race Oncology Ltd

AU:RAC Australia Biotechnology

Market Cap

$335.34 Million

AU$473.93 Million AUD

Market Cap Rank

#14395 Global

#385 in Australia

Share Price

AU$2.43

Change (1 day)

+1.25%

52-Week Range

AU$1.14 - AU$4.70

All Time High

AU$4.70